Gateshead Health NHS Foundation Trust

The Gateshead Health NHS Foundation Trust incorporates Queen Elizabeth Hospital in Gateshead http://www.qegateshead.nhs.uk/

View Trust Services

This trust offers the following services:

  • Diagnostic and pre-operative services:
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Routine Genetic Testing for Lynch Syndrome
  • Surgical services:
    • Robotic surgery
  • Advanced disease services:
    • Dedicated Specialist Advanced MDT
    • Extended lymphadenectomy
  • Support service facilities:
    • Dedicated nurses for ERAS services
    • Availability of 24 hour palliative care advice
    • 7-day access to face-to-face palliative care services

Data Quality

All Patients: Trust Network National
Number of patients in Audit 221 2260 35779
Case ascertainment (%) Good Good Good
Data completeness of:
– Pre-treatment TNM (%) 79 78 86
– Performance status (%) 31 80 89
Patients having major resection: Trust Network National
Number of patients in Audit 88 1313 19631
ASA grade 1 (%) 19 9 9
ASA grade 2 (%) 18 48 53
ASA grade 3 (%) 20 34 31
ASA grade 4+ (%) 1 3 2
ASA grade not recorded (%) 41 6 4
Data completeness of:
7 Audit items for risk-adjustment (%) 59 82 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients

All Patients: Trust Network National
Number of patients in Audit 221 2260 35779
Seen by Clinical Nurse Specialist (%) 77 76 88

Management of patients having major resection

Patients having major resection: Trust Network National
Number of patients in Audit 88 1313 19614
Distant metastases (%) 5 5 5
Urgent or emergency surgery (%) 13 13 15
At least 12 lymph nodes excised (%) 88 82 84
Laparoscopic surgery attempted (%) 93 79 72
Risk-adjusted length of stay > 5 days (%) 47 39 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 75 N/A 10747
Adjuvant chemotherapy (%) 60 N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit 42 N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) 21 N/A 22

Rectal cancer patients

Patients having major resection: Trust Network National
Number of patients in Audit 19 N/A 4251
Neoadjuvant therapy (%) 50 N/A 33
Circumferential resection margin: Recorded (%) 68 87 89
Circumferential resection margin: Negative (%) 68 83 83
Rectal volume 21 N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 146 1373 19644
APER/Hartmanns (%) 34 39 37

Compare trust outcomes